CTIC — CTI Biopharma Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMid Cap
- $1.20bn
- $1.26bn
- $53.95m
CTI Biopharma Corp reports results for the quarter ended in March - Earnings Summary
CTI Biopharma Corp expected to post a loss of 41 cents a share - Earnings Preview
CTI Biopharma Corp reports results for the quarter ended in December - Earnings Summary
Brief: CTI Biopharma Reports Fourth Quarter And Full Year 2021 Financial Results
CTI Biopharma Corp expected to post a loss of 28 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Autozone, Domino's Pizza, Salesforce.com
U.S. STOCKS ON THE MOVE-Vroom, U.S. banks, BigCommerce
CTI Biopharma surges after FDA approves bone marrow drug
Brief: DRI Healthcare Trust Comments On FDA Approval Of Vonjotm (Pacritinib)
NASDAQ RESUMED AT 07:10 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:00 AM
FDA approves CTI BioPharma's bone marrow cancer drug (updated)
FDA approves CTI BioPharma's bone marrow cancer drug
NASDAQ TRADE HALT HALT NEWS PENDING AT 06:10 PM
Brief: CTI BioPharma Presents Data From Pacritinib Program
U.S. STOCKS ON THE MOVE-Ambarella, BeyondSpring, OceanPal, Allbirds
U.S. STOCKS ON THE MOVE-Box, BeyondSpring, Build-A-Bear Workshop, OceanPal
U.S. STOCKS ON THE MOVE-CTI BioPharma, Aditxt, OceanPal, Ardelyx
U.S. STOCKS ON THE MOVE-Longeveron, CTI BioPharma, Aditxt, Merck